TP53 and breast cancer: Breast cancer cells in a 3D culture model exhibiting a disorganized morphology were reverted to a more normal shape when the mutant-p53 was genetically knocked down or the cholesterol biosynthesis pathway was pharmacologically inhibited (Ray et al., 2016).